×

Cystic fibrosis transmembrane conductance regulator gene mutations

  • US 8,124,345 B2
  • Filed: 07/30/2010
  • Issued: 02/28/2012
  • Est. Priority Date: 12/22/2006
  • Status: Active Grant
First Claim
Patent Images

1. A method of determining whether a human is predisposed to cystic fibrosis, comprising determining whether the human is homozygous for the 2777insTG mutation in the cystic fibrosis transmembrane regulatory (CFTR) gene in a nucleic acid sample obtained from the human and identifying the human as having a predisposition to cystic fibrosis when the human is homozygous.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×